Key players like Bayer AG and Fusion Pharmaceuticals are driving innovation in radioligand and alpha-particle therapies, addressing crucial market challenges such as radioisotope supply chain ...

Shanghai Electric (SEHK:2727, SSE:601727) reached two milestone cooperation agreements in the Middle East in early April, signing a 2-gigawatt photovoltaic project agreement with Abu Dhabi Future ...

The market is dominated by the APAC region, with significant growth in dietary supplements and bones & joint health ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The ...

Monsanto, which on April 9 petitioned the U.S. Supreme Court to review its federal preemption defense in a Missouri case, ...

DelveInsight's "HEMLIBRA Market Size, Forecast, and Market Insight Report" highlights the details around HEMLIBRA, a ...

Berman has 25 years of experience in general management and marketing, demonstrating a strong record of driving growth across ...

The Notification Letter has no immediate effect on the Company's listing on the Nasdaq Capital Market at this time, nor are the Company's business operations affected ...

incorporated in the year 1958, is a Mid Cap company (having a market cap of Rs 22,459.81 Crore) operating in Pesticides/Agro Chemicals sector. Bayer Cropscience Ltd. key Products/Revenue Segments ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

Bayer is lobbying U.S. states to adjust their regulatory framework in its battle to wind down costly litigation over its weed killer glyphosate, the German chemicals company’s CEO said in a draft ...